Effect of estradiol and progesterone on rat striatal dopamine uptake sites

Brain Res Bull. 1990 Sep;25(3):419-22. doi: 10.1016/0361-9230(90)90231-n.

Abstract

Striatal dopamine (DA) uptake sites labelled with [3H]GBR-12935 binding were investigated in ovariectomized (OVX) rats acutely treated with 17 beta-estradiol (E2) or progesterone (P). One injection of E2 (100 ng, SC) to OVX rats increased plasma levels of this steroid after 15 min while plasma prolactin (PRL) levels remained unchanged. The E2 injection left striatal [3H]GBR-12935 binding affinity unchanged while the maximum density increased 15 and 30 min after the injection (+24% and +18%, respectively). One injection of P (110 micrograms, SC) to OVX rats increased this steroid plasma level from 15 to 120 min while plasma PRL levels remained unchanged. [3H]GBR-12935 binding density and affinity remained unchanged up to 120 min after the injection. Thus, acutely, E2 but not P, modulated striatal DA uptake sites in OVX rats. The effect of E2 appeared in coincidence with the peak of this steroid plasma concentration. This increase was rapid and is probably nongenomic and suggests a causal effect relationship as well as a presynaptic site of action of E2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Estradiol / blood
  • Estradiol / pharmacology*
  • Female
  • Kinetics
  • Ovariectomy
  • Piperazines / pharmacology
  • Progesterone / blood
  • Progesterone / pharmacology*
  • Prolactin / blood
  • Rats
  • Rats, Inbred Strains

Substances

  • Piperazines
  • Progesterone
  • Estradiol
  • Prolactin
  • 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine
  • Dopamine